Contact Us
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
-
Pay Invoice
Follow Us!
Latest Blogs
- New Kalorama Report Pegs Clinical Lab Services Market at 168BN May 18, 2023
- WHO Reports Lowered Threat Level of COVID-19; What Does it Mean for Testing? May 9, 2023
- SDi Releases Flagship Market Research Report on Analytical and Life Science Instruments: The Global Assessment Report May 3, 2023
- Despite Declines, COVID-19 Still a Large IVD Market May 1, 2023
- Single Cell Genomics Market Reaches $1 Billion April 27, 2023
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
The Market for the Making of IVD Products is 15 Billion: Report
The global in vitro diagnostic (IVD) industry incorporates a sizable contract manufacturing segment that supplies a full range of reagents and test kits, instruments and systems, and testing accessories. This according to Kalorama Information’s latest report on Contract Manufacturing in IVD: https://kaloramainformation.com/product/the-market-for-contract-manufacturing-in-in-vitro-diagnostics-ivd/. The market will grow at double the rate of the overall IVD market, […]
This Week in Cell and Gene Therapy: 11 New Developments to Know (September 12, 2022)
There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. Kite Pharma, a Gilead Company based in Santa Monica, CA, has announced that the European Commission (EC) has granted approval for its chimeric antigen receptor (CAR) T cell therapy Tecartus […]
BCMOs: Who’s Winning?
The global BCMO industry is highly fragmented, with 40 BCMOs/CDMOs accounting for roughly one quarter of the industry’s revenues and the remainder comprised of a large number of smaller players. Based upon 2021 figures, Catalent led the overall market with estimated BCMO sales of $2.2 billion It was followed closely by Cytiva with $2.0 billion […]
CMOs Thrive on New Trend: Pharma Personnel Shortages
Biotechnology BCMO services, including both clinical and commercial production, were estimated at $11.9 billion in 2021. This according to the just-published Kalorama market analysis of the BCMO market. – https://kaloramainformation.com/product/biopharmaceutical-contract-manufacturing-organization-cmo-market-2022/ This segment has been expanding strongly by an estimated 13% per year since 2016, with increased growth of 15.5% per year from 2021 to 2026. […]
What Will Be the Next Emerging Disease Requiring IVDs?
Kalorama estimates a $3.7 billion market for emerging diseases. This market is expected to grow to $4.9 billion in 2026. This is based on it’s latest report: Emerging Infectious Disease Market, released August 2022: https://kaloramainformation.com/product/emerging-infectious-disease-diagnostics-markets-and-trends-2022/ In 2015 the World Health Organization held a workshop on prioritization of pathogens “for accelerated R&D for severe emerging diseases […]
127.4 Billion-Dollar IVD Market Blooms
Abbott Leads, Roche Close Second. COVID -19 Tests Largest Share, But Growth Comes from non-COVID The world in vitro diagnostic (IVD) market will reach $127.4 billion dollars in 2022, according to LabPulse.com’s sister publication Kalorama Information. That’s the finding from the firm’s market research report, The Worldwide Market for In Vitro Diagnostics, 15th edition. REPORT: […]
This Week in Cell and Gene Therapy: 8 New Developments to Know (August 22, 2022)
There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. Prescient Therapeutics, a clinical stage oncology company based in Melbourne, Australia, has signed a five-year manufacturing agreement with Q-Gen Cell Therapeutics, a specialist cell therapy manufacturer based at the QIMR […]
American College of Physicians Discourages DTC Genetic Testing
A recent article in the ACP journal discourages the use of DTC genetic testing and recommends that testing be undertaken in the context of a patient-physician relationship with appropriate counseling. Physicians, healthcare systems, and others with access to patient data must safeguard the privacy, confidentiality, and security of patient information, including genomic information, ACP noted. […]
This Week in Cell and Gene Therapy: 10 New Developments to Know (August 9, 2022)
What You May Have Missed at AACC 2022: Free White Paper
From a biosensor that won AACC’s disruptive technology award, to a new use for AI in IVD, to the realities of automation at real-world laboratories, this year’s AACC conference had a lot to offer. Many Kalorama customers either were not able to make the show or were at the show but may have missed a […]